Rethinking Protein: From Ultra-Processed Hype to Real Food

Key Takeaways

• UK meat sales rose $635 M in 2025, driven by protein demand
• Plant‑based retail fell 4.5% YoY to Jan 2025
• GLP‑1 drugs increase appetite suppression, prompting higher protein intake
• Dairy cottage cheese protein content up 25%, sales jump 40% in 2024
• Ultra‑processed “high‑protein” foods often contain >21% sugar, raising health concerns

Pulse Analysis

The surge in high‑protein consumption reflects a convergence of health science and market dynamics. GLP‑1 medications such as Ozempic, Wegovy and Mounjaro suppress appetite but also accelerate lean‑mass loss, prompting clinicians and influencers to champion protein‑rich diets for muscle repair. This medical backdrop dovetails with the "protein leverage effect," which suggests that insufficient protein drives overeating of carbs and fats, reinforcing the appeal of protein‑dense foods among both men and women seeking weight‑loss solutions.

Retail data underscores the shift: UK plant‑based sales slipped 4.5% in the year to January 2025, while meat expenditures jumped by an estimated $635 million. Dairy innovators have capitalised on the trend; Graham's cottage‑cheese line, boosted by a 25% protein increase, recorded a 40% sales surge in 2024. Even niche products like ready‑made bone broth, priced at about $8.90 for a 500 ml bottle, are gaining shelf space, highlighting consumer willingness to pay a premium for perceived nutrient density.

However, the high‑protein label is increasingly applied to ultra‑processed items that mask sugar, fibre isolates and emulsifiers behind a health halo. Products such as high‑protein chocolate porridge can contain over 21% sugar, raising concerns about long‑term metabolic effects. For manufacturers rooted in sustainable livestock farming, the trend offers an opportunity to promote real, minimally processed protein sources that align with both consumer health goals and environmental stewardship, while regulators and nutritionists must scrutinise the growing wave of engineered protein products.